Panel discussion

ESH eLearning, Faculty / Presenters, 366263

Brief Oral Communication: Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients (Pts) with Very High/High-Risk Myelodysplastic Syndrome (vHR/HR-MDS) and Acute Myeloid Leukaemia (AML): Final Analysis from a Phase Ib Study

ESH eLearning, Andrew Brunner, 366262

Interactive case: Combining checkpoints inhibitors

ESH eLearning, Patrick A. Patrick A. Brown, 366261

Case-based lecture: New developments in CAR-T and NK cell therapy

ESH eLearning, Fabio Ciceri, 366260

Discussion

ESH eLearning, Faculty / Presenters, 366258

CAR T-cell as a bridge to transplant

ESH eLearning, Claire Roddie, 366257

CAR T-cell is a curative ALL therapy

ESH eLearning, Shannon Maude, 366256

Introduction

ESH eLearning, Hervé Dombret, 366255

Discussion

ESH eLearning, Faculty / Presenters, 366254

Post-remission and maintenance treatment for non-transplanted patients

ESH eLearning, Nicholas Short, 366253

Which patients with Ph+ ALL should be transplanted?

ESH eLearning, Sabina Chiaretti, 366252

Initial treatment for Ph+ ALL chemo free or not

ESH eLearning, Yves Chalandon, 366251

Introduction

ESH eLearning, Nicola Gökbuget, 366250

Panel discussion

ESH eLearning, Faculty / Presenters, 366249

Brief Oral Communication: AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib + Azacitidine Versus Placebo + Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

ESH eLearning, Christian RECHER, 366248

Interactive case: The future of IDH inhibitors

ESH eLearning, Eytan Stein, 366247

Case-based lecture: Innovative treatment for relapsed AML

ESH eLearning, Jorge Sierra, 366246

Case-based lecture: Maintenance therapy without transplant

ESH eLearning, Gail Roboz, 366245

Case-based lecture: How to treat FLT3 mutant AML at diagnosis and at relapse?

ESH eLearning, Alexander Perl, 366244

Interactive case: The future of menin inhibitors

ESH eLearning, Eunice Wang, 366243

Panel discussion

ESH eLearning, Faculty / Presenters, 366269

Brief Oral Communication: A Phase Ib Study Exploring MDM2 Inhibitor Siremadlin (HDM201) in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or Very High/High-Risk Myelodysplastic Syndrome

ESH eLearning, Kimmo Porkka, 366268

Case-based lecture: Which AML patients should be transplanted in CR1

ESH eLearning, Raphael Itzykson, 366267

Case-based lecture: Post-transplant maintenance therapies

ESH eLearning, Rita Assi, 366265

Interactive case: Is there a place for transplantation in AML patients not intensively treated frontline?

ESH eLearning, Pierre Fenaux, 366264

Discussion

ESH eLearning, Faculty / Presenters, 366242

The value of pre-transplant MRD in ALL and how to use it?

ESH eLearning, Sebastian Giebel, 366241

The value of pre-transplant MRD in AML and how to use it?

ESH eLearning, Roland B. Walter, 366240

Introduction

ESH eLearning, Charles Craddock, 366239

Discussion

ESH eLearning, Faculty / Presenters, 366238

CON: The reasons to favour venetoclax-azaitidine

ESH eLearning, Courtney DiNardo, 366237

Introduction

ESH eLearning, Farhad Ravandi, 366236

Panel discussion

ESH eLearning, Faculty / Presenters, 366235

Interactive case: What is refractory AML and what to do?

ESH eLearning, Richard Stone, 366233

Case-based lecture: P53 mutant leukaemia: Is there a good treatment approach?

ESH eLearning, David Sallman, 366232

Case-based lecture: Who should receive a RIC transplant?

ESH eLearning, Charles Craddock, 366231

Case-based lecture: Non-intensive treatment for AML: To target or not to target?

ESH eLearning, Paresh Vyas, 366230

Interactive case: How to decide fitness for intensive AML therapy?

ESH eLearning, Lionel Adès, 366229

Panel discussion

ESH eLearning, Faculty / Presenters, 366228

Interactive case: Evaluation of response in non-intensively treated AML patients

ESH eLearning, Farhad Ravandi, 366227

Interactive case: MRD negativity as therapeutic goal in AML

ESH eLearning, Adriano Venditti, 366226

Case-based lecture: Methods for MRD assessment in ALL

ESH eLearning, Jan Trka, 366225

Panel discussion

ESH eLearning, Faculty / Presenters, 366224

Case-based lecture: Early T-cell precursor ALL

ESH eLearning, Wendy Stock, 366223

Interactive case: Ph-like ALL

ESH eLearning, Emily Curran, 366222

Case-based lecture: MPAL with t(9;22)

ESH eLearning, Marielle Wondergem, 366221

Case-based lecture: TP53-mutated AML

ESH eLearning, Lars Bullinger, 366220

Discussion

ESH eLearning, Faculty / Presenters, 366219

Will standard AML cytogenetics become prehistoric?

ESH eLearning, David Spencer, 366218

Introduction

ESH eLearning, Gert Ossenkoppele, 366217

Discussion

ESH eLearning, Faculty / Presenters, 347773

What we can learn from a single case of ENMZL with Multiple Mucosal Sites presentation?

ESH eLearning, Izidore S. Lossos, 347772

Discussion Q & A

ESH eLearning, Faculty / Presenters, 347771

Macroglobulinemia Waldenström – a single centre experience

ESH eLearning, Cátia Sol Reis, 347770

Waldenström macroglobulinemia

ESH eLearning, Jorge Castillo, 347769

Diagnostics

ESH eLearning, Maurilio Ponzoni, 347768

Discussion

ESH eLearning, Faculty / Presenters, 347767

Con

ESH eLearning, Umberto Vitolo, 347766

Pro

ESH eLearning, Nathan Fowler, 347765

Introduction

ESH eLearning, Gilles SALLES, 347764

Discussion Q & A

ESH eLearning, Faculty / Presenters, 347763

Challenges in FL – POD24

ESH eLearning, Emmanuel Bachy, 347762

First line

ESH eLearning, Stefano Luminari, 347761

Allogeneic stem cell transplantation for PTCL patients: Why and when?

ESH eLearning, Gandhi Laurent Damaj, 347758

Introduction

ESH eLearning, Camille Laurent, 347757

Discussion Q & A

ESH eLearning, Faculty / Presenters, 347756

Salvage treatment

ESH eLearning, Pier Luigi Zinzani, 347755

First line treatment

ESH eLearning, Owen A. O’Connor, 347754

Discussion

ESH eLearning, Faculty / Presenters, 347753

Con

ESH eLearning, Peter Johnson, 347752

Pro

ESH eLearning, Joachim Yahalom, 347751

Introduction

ESH eLearning, Marc Andre, 347750

Discussion Q & A

ESH eLearning, Faculty / Presenters, 347749

Refractory/relapsed hodgkin lymphoma: the profile of patients referred to autologous stem cell transplantation

ESH eLearning, Maria Eduarda Couto, 347748

Relapsed Disease

ESH eLearning, Pier Luigi Zinzani, 347747

First line Treatment - Intermediate/Advanced stages

ESH eLearning, Andreas Engert, 347746

First line Treatment - Early stages

ESH eLearning, Marc Andre, 347745

Diagnostics - The boundaries of Hodgkin Lymphoma

ESH eLearning, Stefano Pileri, 347744

Panel Discussion

ESH eLearning, Faculty / Presenters, 349666

Selected Brief Oral Communication: Antitumor Activity and Safety Profile of Subcutaneous Epcoritamab in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Dose-Escalation Data from the Epcore NHL-1 Trial

ESH eLearning, Pieternella Lugtenburg, 349665

CAR T-cell therapies in mantle cell lymphoma

ESH eLearning, Frederick Locke, 349664

Update CAR T-cells

ESH eLearning, Caron Jacobson, 349663

Panel Discussion

ESH eLearning, Faculty / Presenters, 349662

Tailoring therapy in frontline DLBCL

ESH eLearning, Laurie Sehn, 349661

Combining pathway inhibitors in the treatment of CLL

ESH eLearning, Michael Hallek, 349660

Role of BCR inhibitors in the treatment of lymphoma

ESH eLearning, Wyndham Wilson, 349659

Panel Discussion

ESH eLearning, Faculty / Presenters, 349658

Selected Brief Oral Communication: Ibrutinib Blocks CD40 Signalling in Malignant B Cells By Reducing TRAF4 Levels

ESH eLearning, Marek Mraz, 349657

Oncogenic signaling in T-cell lymphoma

ESH eLearning, David Weinstock, 349656

Oncogenic signaling in CLL

ESH eLearning, Adrian Wiestner, 349655

Panel Discussion

ESH eLearning, Faculty / Presenters, 349653

Selected brief oral communication: Clinical Application of an Ex-Vivo Platform to Guide the Choice of Drug Combinations in Relapsed/Refractory Lymphoma; A Prospective Study

ESH eLearning, Anand D., 349652

Role of ctDNA, MRD in the clinic

ESH eLearning, Andrew Rawstron, 349651

Single cell analyses in lymphoma

ESH eLearning, Bertrand Nadel, 349650

Panel Discussion

ESH eLearning, Faculty / Presenters, 349649

Selected brief oral communication: The MYC/MIZ1 Complexes Are Required for Germinal Center B Cell Lymphomagenesis

ESH eLearning, Arief Gunawan, 349648

Panel Discussion

ESH eLearning, Faculty / Presenters, 349647

Selected brief oral communication: Sequential Inverse Dysregulation of the RNA Helicases DDX3X and DDX3Y Facilitates MYC-Driven Lymphomagenesis.

ESH eLearning, Daniel HODSON, 349646

Epigenetic alterations in mantle cell lymphoma

ESH eLearning, José Ignacio, 349645

Role of epigenetic aberrations in DLBCL

ESH eLearning, Ari Melnick, 349644